Roivant Sciences (NASDAQ: ROIV) certainly seems like a rising star. The biotech stock has more than tripled over the past year, soaring to $35 per share and a market cap of $25 billion. Roivant is a ...
Moderna's growth story is just beginning.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results